Table 2 Associations between heritable DNA methylation marks (associated with breast cancer in multiple-case families) and risk of breast cancer in the general population (Melbourne Collaborative Cohort Study)
From: Heritable DNA methylation marks associated with susceptibility to breast cancer
Site | Chr. | Position | Gene name | ORa | 95% CI | p |
|---|---|---|---|---|---|---|
cg06536614 | 5 | 135416381 | VTRNA2-1 (MIR886) | 0.95 | 0.83–1.10 | 0.497 |
cg10306192 | 11 | 102576374 | MMP27 | 1.09 | 0.94–1.27 | 0.235 |
cg18110333 | 6 | 292329 | DUSP22 | 0.96 | 0.83–1.11 | 0.588 |
cg00124993 | 5 | 135416412 | VTRNA2-1 (MIR886) | 0.97 | 0.84–1.12 | 0.667 |
cg26328633 | 5 | 135416394 | VTRNA2-1 (MIR886) | 0.98 | 0.85–1.13 | 0.761 |
cg25340688 | 5 | 135416398 | VTRNA2-1 (MIR886) | 0.95 | 0.82–1.09 | 0.441 |
cg18514595 | 22 | 49579968 | unannotated | 1.14 | 0.99–1.31 | 0.077 |
cg26896946 | 5 | 135416405 | VTRNA2-1 (MIR886) | 0.94 | 0.82–1.09 | 0.426 |
cg11035303 | 3 | 43465503 | ANO10 | 1.01 | 0.88–1.16 | 0.894 |
cg23012654 | 14 | 97493395 | unannotated | 0.95 | 0.83–1.10 | 0.503 |
cg26773954 | 13 | 111969980 | unannotated | 1.02 | 0.88–1.17 | 0.813 |
cg22901919 | 4 | 141317067 | CLGN | 0.91 | 0.78–1.06 | 0.224 |
cg04417708 | 17 | 4043867 | ZZEF1 | 1.00 | 0.87–1.15 | 0.989 |
cg18584561 | 2 | 11682017 | GREB1 | 1.18 b | 1.03–1.36 | 0.015 |
cg11608150 | 5 | 135415948 | unannotated | 0.93 | 0.80–1.07 | 0.311 |
cg01741999 | 2 | 219137824 | PNKD | 1.26 | 1.03–1.54 | 0.027 |
cg01074083 | 16 | 17516862 | XYLT1 | 0.98 | 0.84–1.13 | 0.749 |
cg02096220 | 4 | 129212177 | unannotated | 1.02 | 0.89–1.18 | 0.743 |
cg03916490 | 7 | 1080558 | C7orf50 | 0.83 | 0.72–0.96 | 0.012 |
cg27639199 | 15 | 81666528 | TMC3 | 1.19 | 1.03–1.36 | 0.018 |
cg25188166 | 3 | 119420208 | unannotated | 0.96 | 0.83–1.10 | 0.551 |
cg05865327 | 14 | 102274741 | PPP2R5C | 1.04 | 0.90–1.20 | 0.589 |
cg23947138 | 13 | 114782778 | RASA3 | 0.89 | 0.78–1.02 | 0.091 |
cg05187003 | 21 | 34641507 | IL10RB | 1.00 | 0.86–1.15 | 0.950 |